home All News open_in_new Full Article

Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches

Number of patients reached in 2024 jumps 8% to 66 million  R&D investments rise to EUR 6.2 billion, 23.2% of group net sales Company prepares new product launches starting in 2025 Boehringer Ingelheim today announced a continued rise in the number of patients it reached, 66 million in 2024, up 8.0% from the previous year. […]


today 67 h. ago attach_file Science

attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Events
attach_file Economics
attach_file Society
attach_file Transport
attach_file Technology
attach_file Other
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Sport
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Other
attach_file Society


ID: 475244674
Add Watch Country

arrow_drop_down